FFICM Final Examination Pass Rate 2026
The headline figure
The FICM publishes per-component pass rates for the FFICM Final Examination. These are the most recent verified figures:
- MCQ (June 2025 sitting): 88.49% (Jun 2025) - official source, verified 2026-07-24.
- MCQ (January 2025 sitting): 81.22% (Jan 2025) - official source, verified 2026-07-24.
- OSCE/SOE clinical phase (March 2025 sitting): 68.72% (Mar 2025) - official source, verified 2026-07-24.
- OSCE/SOE clinical phase (October 2024 sitting): 56.04% (Oct 2024) - official source, verified 2026-07-24.
FICM publishes pass rates per sitting. The FFICM Examination Annual Report 2024-25 (the most recent published) reports the MCQ at 84.23% across the 2024-25 academic year (336 attempts, including resits) and the combined OSCE/SOE clinical phase at 62.19% (402 attempts). By component across that year the OSCE ran 69.38% and the SOE 72.16%. October OSCE/SOE sittings historically run lower than March sittings. Results of the June 2026 MCQ had not been released as of 2026-07-24 (delayed to 28 July 2026).
How the standard is set
For the FFICM Final Examination, FICM assesses candidates against a defined competency standard rather than ranking them against each other, so the proportion who pass reflects how a cohort performs against that bar and varies between sittings. Where a verified figure is published it appears above with its source; where the examining body publishes none, PRIMEX states that plainly rather than estimating one.
What separates pass-tier from fail-tier candidates
Three separately marked components: an all-SBA written MCQ, then a 13-station OSCE and a four-station Structured Oral (SOE) taken together.
Examiner reports and feedback consistently flag the following preparation pitfalls among candidates who fall short:
- Applied basic science gaps - the Faculty's own reports repeatedly flag pharmacology (mechanisms, interactions, adverse effects) and physiology (ventilation, cardiac tamponade, maternal physiology, renal failure) as weak areas.
- Data interpretation under time pressure: blood results, microscopy and biochemistry of body fluids recur across the written and clinical components.
- Treating the OSCE and SOE as an afterthought - the clinical phase consistently passes a markedly smaller share of candidates than the written paper.
- Paediatric stabilisation and practical procedures (venous access, renal replacement therapy, chest drains, cardiac pacing) - recurring weak areas in the examiner reports.
How PRIMEX helps you cross the pass line
- Five-option single best answer bank modelled on the all-SBA FFICM written paper, with grounded per-option explanations.
- Structured Oral (SOE) simulator with voice mode: clinical openings, prioritised management probing and UK guidance expectations.
- UK study notes across 310 syllabus-mapped learning objectives, with spaced-repetition flashcards.
Start your 7-day free PRIMEX trial for the FFICM Final Examination and find out exactly where your preparation stands.
Start free trial7-day free trial · Cancel anytime
Frequently asked questions
How long should I study for the FFICM Final Examination?
Most candidates dedicate 26-52 weeks of structured preparation for the FFICM Final Examination. The exact duration depends on your prior knowledge base, clinical experience, and available study time per week. Starting earlier generally produces better outcomes than compressing preparation into a short period.
What is the format of the FFICM Final Examination?
Three separately marked components: an all-SBA written MCQ, then a 13-station OSCE and a four-station Structured Oral (SOE) taken together.
What is the pass rate for the FFICM Final Examination?
The FICM publishes per-component pass rates for the FFICM Final Examination. These are the most recent verified figures:
- MCQ (June 2025 sitting): 88.49% (Jun 2025) - official source, verified 2026-07-24.
- MCQ (January 2025 sitting): 81.22% (Jan 2025) - official source, verified 2026-07-24.
- OSCE/SOE clinical phase (March 2025 sitting): 68.72% (Mar 2025) - official source, verified 2026-07-24.
- OSCE/SOE clinical phase (October 2024 sitting): 56.04% (Oct 2024) - official source, verified 2026-07-24.
FICM publishes pass rates per sitting. The FFICM Examination Annual Report 2024-25 (the most recent published) reports the MCQ at 84.23% across the 2024-25 academic year (336 attempts, including resits) and the combined OSCE/SOE clinical phase at 62.19% (402 attempts). By component across that year the OSCE ran 69.38% and the SOE 72.16%. October OSCE/SOE sittings historically run lower than March sittings. Results of the June 2026 MCQ had not been released as of 2026-07-24 (delayed to 28 July 2026).
What are the most common failure modes in the FFICM Final Examination?
- Applied basic science gaps - the Faculty's own reports repeatedly flag pharmacology (mechanisms, interactions, adverse effects) and physiology (ventilation, cardiac tamponade, maternal physiology, renal failure) as weak areas.
- Data interpretation under time pressure: blood results, microscopy and biochemistry of body fluids recur across the written and clinical components.
- Treating the OSCE and SOE as an afterthought - the clinical phase consistently passes a markedly smaller share of candidates than the written paper.
- Paediatric stabilisation and practical procedures (venous access, renal replacement therapy, chest drains, cardiac pacing) - recurring weak areas in the examiner reports.
What resources does PRIMEX provide for the FFICM Final Examination?
PRIMEX provides a curriculum-mapped question bank, AI-graded practice, and structured study resources for the FFICM Final Examination. Start with a 7-day free trial to access the full platform.